Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Babyscripts Mobile App To Help Clinicians Deliver Improved Prenatal Care

XTALKS VITALS NEWS

Prenatal

The Babyscripts app prompts patients to measure their blood pressure and weight at least once per week – data which is transmitted to the physician using Wi-Fi for remote monitoring.

Tweetables from this article:

Tweet: Babyscripts was developed alongside obstetrician/gynecologists at George Washington University #prenatalhealth http://ctt.ec/3zOp4+Babyscripts was developed alongside obstetrician/gynecologists at George Washington University.

Tweet: Babyscripts is first mobile app aimed at allowing clinicians to remotely monitor their expecting patients’ health http://ctt.ec/O2192+Babyscripts is first mobile app aimed at allowing clinicians to remotely monitor their expecting patients’ health.

Share this!

August 22, 2016 | by Sarah Massey, M.Sc.

According to Anish Sebastian, the White House Champion of Change in Precision Medicine, pregnancy apps are the second most downloaded in the health and fitness category. In light of this, Sebastian and his business partner Juan Pablo Segura, created the first mobile app aimed at allowing clinicians to remotely monitor their expecting patients’ health.

The clinical tool – called Babyscripts – was developed alongside obstetrician/gynecologists at George Washington University. Once a clinic signs up to use the tool in their practice, low-risk patients interested in the technology are provided with a wireless blood pressure cuff and weigh scale contained in a “Mommy Kit.”

The Babyscripts app prompts patients to measure their blood pressure and weight at least once per week – data which is transmitted to the physician using Wi-Fi for remote monitoring. The home-based data collection could allow obstetricians to identify high blood pressure or excessive weight gain earlier than they normally would at a monthly prenatal appointment.

“Patients don’t have to come in as often, but you’re capturing ten times as much data,” said Segura. In validating the app with George Washington University researchers, Babyscripts was first tested with low-risk pregnancies.



The researchers recently presented their clinically-relevant findings from the weigh scale and blood pressure data at the American College of Obstetricians and Gynecologists meeting. According to Segura, among the 200 women with completed pregnancies and 1,000 pregnant women currently using the app, compliance has been around 85 percent. This indicates that women are using the devices and the app following the suggested testing schedule, and physicians are collecting valuable data.

By the end of 2016, Segura expects to have 3,000 pregnant patients using the platform, with the potential to expand that number to 30,000 women who attend one of ten healthcare provider networks in the US who have adopted Babyscripts. According to Segura, the pregnancy apps category is a popular but “mysterious” category.

“A majority of pregnancies are low risk, but things can change suddenly and quickly,” said Segura. Both pre-eclampsia and gestational diabetes are among the most common health issues during pregnancy, which require medical intervention to improve outcomes for both mom and baby.

Luckily, high blood pressure and high blood sugar are useful biomarkers for pre-eclampsia and gestational diabetes, respectively. Multiple cases of pre-eclampsia have been diagnosed earlier thanks to the data collected using the Babyscripts platform, and the team are developing an expanded Babyscripts Plus kit which could include a glucometer to detect gestational diabetes.

“The goal we’ve had from the get-go is not just to stay within the low-risk category but to offer more services to low-risk patients,” said Segura. “The idea is to completely rethink how all of pregnancy care can be delivered in a risk-based model.”


Keywords: App, Prenatal, Clinical Tool


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Exclusion Criteria for Clinical Trials Poses Major Barrier to Patient Enrollment

August 17, 2017 - UT Southwestern researchers say that clinical investigators continue to increase the number of exclusion criteria, preventing more patients from participating in clinical trials.

Featured In: Clinical Trials News


Targeting Cellular Nitrogen Metabolism Could Offer a New Treatment for Pancreatic Cancer

August 17, 2017 - An enzyme involved in regulating the amount of nitrogen in the cell could be a new drug target for pancreatic cancer, according to researchers from Boston Children's Hospital and the Broad Institute of MIT and Harvard.

Featured In: Life Science News


Regeneron’s Drug for Respiratory Syncytial Virus Fails in Phase III Clinical Trial

August 16, 2017 - Biotechnology company Regeneron has announced it will not continue development of its antibody drug, suptavumab, after a failure in a Phase III clinical trial.

Featured In: Clinical Trials News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

One Patient’s Perspective on Clinical Trials

REGISTER FOR THESE WEBINARS

Planning and Conducting Trials of the Latest Immunotherapies


ISO 13485:2016 for Medical Device Manufacturers: Ensuring a Smooth Transition through Effective Preparation


Medical Devices: Reviewing Regulatory Changes in the US and EU


Moving Beyond Regulatory and Performance Metrics in Starting Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.